Detalhe da pesquisa
1.
Antibiotic resistance in the patient with cancer: Escalating challenges and paths forward.
CA Cancer J Clin
; 71(6): 488-504, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34546590
2.
Patient Access in 14 High-Income Countries to New Antibacterials Approved by the US Food and Drug Administration, European Medicines Agency, Japanese Pharmaceuticals and Medical Devices Agency, or Health Canada, 2010-2020.
Clin Infect Dis
; 74(7): 1183-1190, 2022 04 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34251436
3.
Antimicrobial Resistance: Is Health Technology Assessment Part of the Solution or Part of the Problem?
Value Health
; 24(12): 1828-1834, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34838281
4.
International cooperation to improve access to and sustain effectiveness of antimicrobials.
Lancet
; 387(10015): 296-307, 2016 Jan 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-26603920
5.
Progress in the Fight Against Multidrug-Resistant Bacteria? A Review of U.S. Food and Drug Administration-Approved Antibiotics, 2010-2015.
Ann Intern Med
; 165(5): 363-72, 2016 09 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27239977
6.
Antibacterial R&D at a Crossroads: We've Pushed as Hard as We Can Now We Need to Start Pulling!
Clin Infect Dis
; 73(11): e4451-e4453, 2021 12 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32584949
7.
Antibiotic Development Incentives That Reflect Societal Value of Antibiotics.
Clin Infect Dis
; 72(9): e420-e421, 2021 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31999818
8.
Delinking Investment in Antibiotic Research and Development from Sales Revenues: The Challenges of Transforming a Promising Idea into Reality.
PLoS Med
; 13(6): e1002043, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27299990
9.
A roadmap for sustainably governing the global antimicrobial commons.
Lancet
; 394(10211): 1788-1789, 2019 11 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-31741444
10.
Social, cultural and economic aspects of antimicrobial resistance.
Bull World Health Organ
; 98(12): 823-823A, 2020 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33293739
11.
The Fight Against Multidrug-Resistant Bacteria.
Ann Intern Med
; 166(1): 79, 2017 01 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28030672
12.
The Drug Quality and Security Act--mind the gaps.
N Engl J Med
; 370(2): 97-9, 2014 Jan 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-24369048
13.
Clinical trial transparency--antidote to weaker off-label-promotion rules?
N Engl J Med
; 371(1): 1-3, 2014 Jul 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-24988551
14.
Introduction: AMR Belongs in the Pandemic Instrument.
J Law Med Ethics
; 50(S2): 6-8, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36889349
15.
A Pandemic Instrument Can Start Turning Collective Problems into Collective Solutions by Governing the Common-Pool Resource of Antimicrobial Effectiveness.
J Law Med Ethics
; 50(S2): 17-25, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36889344
16.
Estimating The Appropriate Size Of Global Pull Incentives For Antibacterial Medicines.
Health Aff (Millwood)
; 40(11): 1758-1765, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34724432
17.
The impact of infections on reimbursement in 92 US hospitals, 2015-2018.
Am J Infect Control
; 49(10): 1275-1280, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33891989
18.
The effect of generic market entry on antibiotic prescriptions in the United States.
Nat Commun
; 12(1): 2937, 2021 05 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34006862
19.
Punishing health care fraud--is the GSK settlement sufficient?
N Engl J Med
; 367(12): 1082-5, 2012 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-22970920
20.
Regulating compounding pharmacies after NECC.
N Engl J Med
; 367(21): 1969-72, 2012 Nov 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-23134357